Drug Data Manipulation Is Merely More of the Same
The Daily Bell
Medtronic
Manipulated Bone Product Data, Senators Say... Medtronic Inc. (MDT)
ghost-wrote sections of medical papers and paid physician authors
hundreds of millions of dollars in "consulting fees" to
promote its bone-growth product Infuse, a U.S. Senate investigation
found. Medtronic, the world's biggest maker of heart-rhythm devices,
helped write, edit and shape at least 11 medical journal articles
about the product, which is used to spur bone growth after spinal
surgery, according to report released today by the Senate Finance
Committee. The doctors and researchers who were the authors of the
studies were part of a $210 million consulting and royalty payments
program by Minneapolis-based Medtronic and never disclosed their
ties or the company's influence in their papers, the panel said
in its report. ~ Bloomberg
Dominant
Social Theme: This is an aberration!
Free-Market
Analysis: We're not surprised about this only because we've
lost our capacity to be shocked. These days we're surprised only
if our worst expectations are NOT fulfilled.
Everything
and we do mean everything in Western culture and corporate
enterprise is bent toward global governance. That's all that seemingly
matters.
Many US high
schools turn out dropouts at a rate approaching 50 percent. University
education is farcical. People are "educated" with lies
and when they get out of school, they can't find jobs anyway.
Physics refuses
to recognize the primacy of the electrical universe, or even to
investigate it. Music and the arts are milked of grand ambitions
or attenuated by teen angst.
Oil is said
to be running out when the world is swimming in oil. The weather
is said to be warming when it may be cooling. Even the air contains
too much carbon dioxide and must be drained.
Movies purvey
dominant social themes. Politics promotes the idea of a war on terror
that does not exist. In many cases, Homeland Security and the FBI
literally create the threats they then subdue.
Money is a
big issue. Central banks are said to fight inflation when they cause
it. The euro is said to be Europe's salvation when it is, in fact,
its ruination. Gold is a barbaric relic, according to the powers-that-be,
even though it's gone up nearly tenfold in the past decade.
Corporations
are said to be efficient when, in fact, they only exist because
of judicial fiat. And speaking of the judiciary, public justice
is presented as impartial when the harsh reality is government funding
for every part of the judicial apparatus makes it rife with conflicts
of interest and extremely corrupt.
Why should
the pharmaceutical industry be any different? The corruption is
significant because many of the drugs that are marketed don't work
as advertised and thus threaten people's health, in many cases with
significant side effects. Here's more from the article:
"Medtronic's
actions violate the trust patients have in their medical care,"
Senator Max Baucus, a Montana Democrat and committee chairman,
said in a statement. "Medical journal articles should convey
an accurate picture of the risks and benefits of drugs and medical
devices, but patients are at serious risk when companies distort
the facts the way Medtronic has."
Sales of
Infuse plunged after The Spine Journal published studies in May
2011 and June 2011 showing the genetically engineered protein
raised the risk of infertility, infections and cancer. Revenue
from the product was $195 million in the three months ended in
January 2011 and fell to $141 million in the three months ended
July 27, the company reported.
Medtronic
rose 0.3 percent to $41.69 at the close in New York yesterday
for a gain of 9 percent this year. The stock traded in Europe
rose 0.1 percent to $41.73 on volume of 250 shares at 10:05 a.m.
in Frankfurt.
"Medtronic
was involved in drafting, editing, and shaping the content of
medical journal articles authored by its physician consultants
who received significant amounts of money through royalties and
consulting fees from Medtronic," Baucus and Senator Charles
Grassley, an Iowa Republican, said in a statement. Part of that
influence was inserting language into one study that emphasized
the pain caused by a competing technique to Infuse, the senators
said.
Infuse was
approved in 2002 for use in fusing damaged vertebrae in the lower
spine. It has never been approved for the upper, or cervical spine,
where it is now widely used. The Food and Drug Administration
warned surgeons not to use the product on the cervical spine in
July 2008 after learning of complications in dozens of patients
that included trouble breathing and eating.
More than
140,000 spinal fusion surgeries were performed with Infuse in
2009, according to the Agency for Healthcare Research and Quality.
Of those, only 21,240 were done using the product with a technique
that's approved by regulators, bolstering the contention that
more than 85 percent of Infuse's use is in patients who aren't
formally cleared to receive it, the senators said in the report.
We see from
this reporting that, once again, what is purveyed as reality has
little resemblance to it. And we would argue this is because the
pharmaceutical industry and health care industry generally are false
flags of sorts.
It is little
known that many drugs are discovered in the wild, often in the Amazon,
and then their effects are mimicked in the lab because that's the
only way to patent them. Creating artificial drugs manufactures
terrible side effects, as well. Almost all drugs come with these
side effects, in some cases maiming and killing millions over time.
The industry
knows this and thus, scientific journals have been perverted to
present false articles and research on a regular basis. We'd go
so far as to project that most important new drugs have some level
of falsified research. The research doesn't have to be overtly falsified.
The timeline can simply be investigated in such a way as to preclude
an elongation that would expose the presentation of eventual side
effects.
Or the research
can be falsified outright. More and more these days that seems to
be the case, though doubtless it is the modern communications that
is responsible for the prevalence of the exposure more often than
in the past.
Vaccines represent
perhaps Big Pharma's deadliest scam. Some vaccines may work but
it's hard to tell. What is most evident is that Big Pharma doesn't
actually do much testing when it comes to vaccines, let alone double-blind
testing.
The efficacy
of flu vaccines is in doubt. And the administering of several vaccines
at once is said to bring on autism in a percentage of sensitive
children. We're only surprised the Medtronics findings have come
out at all, much less through a congressional investigation. Congress
is usually part of the problem.
Medtronic execs
rejected many of the report's findings. But probably its legal department
was surprised it even had to do so. After all, the US Department
of Justice and the Office of the US Attorney in Boston "conducted
a four-year investigation of the company's handling of Infuse marketing
and closed the case in May without any finding."
Clinical trials
funded by Medtronic reported NO side effects from Infuse. For some
reason, however, "data provided to the FDA showed as many as
half of patients had complications including infections, pain, cysts
and cancer." Two of the "independent reviewers" of
Infuse received compensation from Medtronic on the order of $7.8
million and $722,000. These are astonishing sums.
Medtronics
is still in the funding business, however. According to Bloomberg,
Harlan Krumholz, "a Yale University professor of internal medicine,
epidemiology and public health, is conducting an independent analysis
of Medtronic's Infuse data funded by a $2.5 million grant from the
company."
"Sometimes
what you are reading about in a study may not be everything,"
Krumholz said in an interview before the Senate committee's report
was released. "We have to change the way this kind of science
has been conducted."
Conclusion:
You think?
Reprinted
with permission from The
Daily Bell.
October
27, 2012
Copyright
© 2012 The
Daily Bell
|